Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida Hed Myrberg

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Blood Cancer Journal|October 21, 2018
Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimensGeorge Z Rassidakis, Nikolas Herold, Ida Hed Myrberg, et al.
Blood|July 24, 2024
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisitedJan-Inge Henter, Elena Sieni, Julia Eriksson, et al.
Haematologica|March 31, 2022
Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypesStavroula Anastasopoulou, Rikke Linnemann Nielsen, Bodil Als-Nielsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2021
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severityEgle Kvedaraite, Laura Hertwig, Indranil Sinha, et al.
Nature Medicine|January 10, 2017
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignanciesNikolas Herold, Sean G Rudd, Linda Ljungblad, et al.
EMBO Molecular Medicine|January 18, 2020
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacySean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Blood Cancer Journal|October 21, 2018
Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimensGeorge Z Rassidakis, Nikolas Herold, Ida Hed Myrberg, et al.
Blood|July 24, 2024
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisitedJan-Inge Henter, Elena Sieni, Julia Eriksson, et al.
Haematologica|March 31, 2022
Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypesStavroula Anastasopoulou, Rikke Linnemann Nielsen, Bodil Als-Nielsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2021
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severityEgle Kvedaraite, Laura Hertwig, Indranil Sinha, et al.
Nature Medicine|January 10, 2017
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignanciesNikolas Herold, Sean G Rudd, Linda Ljungblad, et al.
EMBO Molecular Medicine|January 18, 2020
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacySean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, et al.
Pageof 4